Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythropoietin for Neurodevelopment in Preterm Infants with IVH
NCT03914690Phase 2Completed
- Sponsor
- Zhengzhou University
- Start
- Jul 2014
- Primary completion
- Jul 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of erythropoietin in Intraventricular hemorrhage (IVH) (2 arms), sponsored by Zhengzhou University. Primary endpoints: Mortality and Incidence of Neurological Disability. Started Jul 2014; status: completed.
02
Drugs
erythropoietin
03
Conditions
Intraventricular hemorrhage (IVH)
Beyond the preview
Go deeper on NCT03914690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03914690.